Dianthus Therapeutics's total assets for Q4 2025 were $530.92M, a decrease of -8.06% from the previous quarter. DNTH total liabilities were $37.52M for the fiscal quarter, a 21.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.